💊 Препараты А-Я 🧬 Мишени 🛠 Инструменты 📚 Руководства
Все препараты Классы препаратов Терапевтические области Побочные Эффекты
Руководства Глоссарий Хронология
Сравнения Путешествия препаратов Группы лекарственных средств
🇺🇸 English 🇰🇷 한국어 🇯🇵 日本語 🇨🇳 中文简体 🇪🇸 Español 🇧🇷 Português 🇮🇳 हिन्दी 🇸🇦 العربية 🇫🇷 Français 🇷🇺 Русский 🇩🇪 Deutsch 🇹🇷 Türkçe 🇻🇳 Tiếng Việt 🇮🇩 Bahasa Indonesia 🇹🇭 ไทย

Sodium Succinate

CHEMBL1200345 Phase 4 Одобрено Small molecule
Half-Life
—
Bioavailability
—
Protein Binding
—
Molecular Weight
162.0 g/mol
LogP
—
Phase
4

Sodium succinate is the sodium salt of succinic acid, a Krebs cycle intermediate used as a pharmaceutical excipient, buffering agent, and in parenteral nutrition formulations to provide a metabolizable organic anion. Succinate is an important cellular energy substrate and signaling molecule, and intravenous formulations have been investigated in conditions including asthma and chronic kidney disease for their potential cytoprotective and anti-inflammatory properties. It is also used as a stabilizer in corticosteroid injectable preparations.

Молекулярная масса

162,0500 g/mol

TPSA

80,30 Ų

Терапевтические области

Pain Management Asthma Chronic Obstructive Pulmonary Disease Epilepsy Migraine Infectious Disease Melanoma Systemic Lupus Erythematosus Chronic Kidney Disease Non-Alcoholic Fatty Liver Disease Stroke Lymphoma Malaria Heart Failure Leukemia

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D Структура

SVG PNG

Cite this structure


                        

                            
                            
                        

                    

                


                
                

                    

                    

                        
Embed this structure

                        

                        

                            
                            
                        

                    

                

                

                
                

                    
SMILES

                    
O=C([O-])CCC(=O)O.[Na+]

                

                

                
                

                    
InChI

                    
InChI=1S/C4H6O4.Na/c5-3(6)1-2-4(7)8;/h1-2H2,(H,5,6)(H,7,8);/q;+1/p-1

                

                

                

                    
                    

                        
Molecular Formula

                        
C4H4Na2O4

                    

                    
                    

                        
HBD / HBA

                        
- / 4

                    

                    
                    

                        
Вращаемые Связи

                        
1

                    

                    
                    
                    

                        
Тяжёлые Атомы

                        
10

                    

                    
                

            


            
            

                
                


    
    
        
    
    
    
No targets recorded

    
    
Target interaction data is not yet available for this drug.

    



                
            


            
            

                
                


    
    
        
    
    
    
No interactions recorded

    
    
Drug interaction data is not yet available for this compound.

    



                
            


            
            

                
                


    
    
        
    
    
    
No side effects recorded

    
    
Side effect data is not yet available for this drug.

    



                
            


            
            
            

                
Часто задаваемые вопросы

                

                    
                    

                        
                        

                            
Sodium succinate is the sodium salt of succinic acid, a Krebs cycle intermediate used as a pharmaceutical excipient, buffering agent, and in parenteral nutrition formulations to provide a metabolizable organic anion. Succinate is an important cellular energy substrate and signaling molecule, and intravenous formulations have been investigated in conditions including asthma and chronic kidney disease for their potential cytoprotective and anti-inflammatory properties. It is also used as a stabilizer in corticosteroid injectable preparations.

                        

                    

                    

                    

                    

                    

                    

                        
                        

                            
Yes, Sodium Succinate is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

                        

                    

                

            

            

            
            

            
            

            
            
{# References & Data Sources section for drug detail pages.
   Renders standard pharmacological database links plus the drug's data_sources field. #}


    
References & Data Sources

    
    
        
        
  • 
            
            
                ChEMBL — European Bioinformatics Institute (EBI).
                CHEMBL1200345.
                Open-access bioactivity database.
            
        
    • 
        
        
        
  • 
            
            
                PubChem — National Center for Biotechnology Information (NCBI).
                CID 9020.
                Chemical information database.
            
        
    • 
        
        
        
        
    

    
Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.




        


        
        
    


    



    
Медицинский отказ от ответственности

    

        This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.
    

    

        Data sources:
        ChEMBL,
        PubChem,
        DailyMed.